US FDA panel votes against approval of Intercept fatty liver drug, points to safety issues – Reuters

US FDA panel votes in opposition to approval of Intercept fatty liver drug, citing questions of safety Reuters
#FDA #panel #votes #approval #Intercept #fatty #liver #drug #factors #security #points #Reuters